nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A broad protection provided by matrix protein 2 (M2) of avian influenza virus
|
Meng, Qingwen |
|
2015 |
33 |
31 |
p. 3758-3765 8 p. |
artikel |
2 |
A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein
|
Guo, Long-Jun |
|
2015 |
33 |
31 |
p. 3752-3757 6 p. |
artikel |
3 |
A cyclophosphamide-sensitive cell compartment is essential for homologous protection conferred by licensed vaccines for the control of avian pathogenic Escherichia coli in chickens
|
Sadeyen, Jean-Rémy |
|
2015 |
33 |
31 |
p. 3624-3627 4 p. |
artikel |
4 |
An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers
|
Tabynov, Kaissar |
|
2015 |
33 |
31 |
p. 3619-3623 5 p. |
artikel |
5 |
Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing
|
Zahid, Maria |
|
2015 |
33 |
31 |
p. 3739-3745 7 p. |
artikel |
6 |
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency
|
Loubet, Paul |
|
2015 |
33 |
31 |
p. 3703-3708 6 p. |
artikel |
7 |
Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans
|
Schiffer, Jarad M. |
|
2015 |
33 |
31 |
p. 3709-3716 8 p. |
artikel |
8 |
Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006–2014
|
Stefanelli, P. |
|
2015 |
33 |
31 |
p. 3678-3681 4 p. |
artikel |
9 |
Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines
|
Salazar-González, Jorge A. |
|
2015 |
33 |
31 |
p. 3650-3658 9 p. |
artikel |
10 |
Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation
|
Regan, A.K. |
|
2015 |
33 |
31 |
p. 3689-3694 6 p. |
artikel |
11 |
Congenital rubella syndrome (CRS) in Vietnam 2011–2012—CRS epidemic after rubella epidemic in 2010–2011
|
Toda, Kohei |
|
2015 |
33 |
31 |
p. 3673-3677 5 p. |
artikel |
12 |
Editorial Board/Aims and Scope
|
|
|
2015 |
33 |
31 |
p. IFC- 1 p. |
artikel |
13 |
Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination
|
Bento, Dulce |
|
2015 |
33 |
31 |
p. 3609-3613 5 p. |
artikel |
14 |
Guillain-Barré syndrome and influenza vaccines: A meta-analysis
|
Martín Arias, L.H. |
|
2015 |
33 |
31 |
p. 3773-3778 6 p. |
artikel |
15 |
Health benefit for the child and promotion of the common good were the two most important reasons for participation in the FinIP vaccine trial
|
Nieminen, Heta |
|
2015 |
33 |
31 |
p. 3695-3702 8 p. |
artikel |
16 |
Immune response triggered by Brucella abortus following infection or vaccination
|
Dorneles, Elaine M.S. |
|
2015 |
33 |
31 |
p. 3659-3666 8 p. |
artikel |
17 |
Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age
|
Janssen, Julia M. |
|
2015 |
33 |
31 |
p. 3614-3618 5 p. |
artikel |
18 |
Influence of maternally-derived antibodies on live attenuated influenza vaccine efficacy in pigs
|
Pyo, Hyun Mi |
|
2015 |
33 |
31 |
p. 3667-3672 6 p. |
artikel |
19 |
Introduction of a National HPV vaccination program into Bhutan
|
Dorji, Tandin |
|
2015 |
33 |
31 |
p. 3726-3730 5 p. |
artikel |
20 |
Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
|
Dorigatti, Ilaria |
|
2015 |
33 |
31 |
p. 3746-3751 6 p. |
artikel |
21 |
Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines
|
Oviedo-Orta, Ernesto |
|
2015 |
33 |
31 |
p. 3628-3635 8 p. |
artikel |
22 |
Report of the 2014 Cent Gardes HIV Vaccine Conference – Part 1: Neutralizing Antibodies; Fondation Mérieux Conference Center, Veyrier du Lac, France, 5–7 October 2014
|
Girard, Marc P. |
|
2015 |
33 |
31 |
p. 3605-3608 4 p. |
artikel |
23 |
Risk of febrile seizure after measles–mumps–rubella–varicella vaccine: A systematic review and meta-analysis
|
Ma, Shu-Juan |
|
2015 |
33 |
31 |
p. 3636-3649 14 p. |
artikel |
24 |
Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults
|
Fix, Alan D. |
|
2015 |
33 |
31 |
p. 3766-3772 7 p. |
artikel |
25 |
Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults
|
Kennedy, Richard B. |
|
2015 |
33 |
31 |
p. 3682-3688 7 p. |
artikel |
26 |
The doses of 10μg should replace the doses of 5μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis
|
Yin, Juan |
|
2015 |
33 |
31 |
p. 3731-3738 8 p. |
artikel |
27 |
Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14–15 years
|
Carlsson, R.M. |
|
2015 |
33 |
31 |
p. 3717-3725 9 p. |
artikel |